Impact of antibiotics on gut microbiome composition and resistome in the first years of life in low- to middle-income countries: A systematic review
PLOS Medicine · 27.06.2023 · 20 (6) · e1004235
DOI: 10.1371/journal.pmed.1004235 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PLOS Medicine, online erschienen am 27.06.2023. Verfasst von Charlie C Luchen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam UMC, location University of Amsterdam, Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam, the N…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Gastrointestinal Microbiome. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, The Netherlands Organization for Health Research and Development, Health Holland TKI.
Abstract (Originalsprache)
Background
Inappropriate antimicrobial usage is a key driver of antimicrobial resistance (AMR). Low- and middle-income countries (LMICs) are disproportionately burdened by AMR and young children are especially vulnerable to infections with AMR-bearing pathogens. The impact of antibiotics on the microbiome, selection, persistence, and horizontal spread of AMR genes is insufficiently characterized and understood in children in LMICs. This systematic review aims to collate and evaluate the available literature describing the impact of antibiotics on the infant gut microbiome and resistome in LMICs. Methods and findings In this systematic review, we searched the online databases MEDLINE (1946 to 28 January 2023), EMBASE (1947 to 28 January 2023), SCOPUS (1945 to 29 January 2023), WHO Global Index Medicus (searched up to 29 January 2023), and SciELO (searched up to 29 January 2023). A total of 4,369 articles were retrieved across the databases. Duplicates were removed resulting in 2,748 unique articles. Screening by title and abstract excluded 2,666 articles, 92 articles were assessed based on the full text, and 10 studies met the eligibility criteria that included human studies conducted in LMICs among children below the age of 2 that reported gut microbiome composition and/or resistome composition (AMR genes) following antibiotic usage. The included studies were all randomized control trials (RCTs) and were assessed for risk of bias using the Cochrane risk-of-bias for randomized studies tool. Overall, antibiotics reduced gut microbiome diversity and increased antibiotic-specific resistance gene abundance in antibiotic treatment groups as compared to the placebo. The most widely tested antibiotic was azithromycin that decreased the diversity of the gut microbiome and significantly increased macrolide resistance as early as 5 days posttreatment. A major limitation of this study was paucity of available studies that cover this subject area. Specifically, the range of antibiotics assessed did not include the most commonly used antibiotics in LMIC populations.
Conclusion
In this study, we observed that antibiotics significantly reduce the diversity and alter the composition of the infant gut microbiome in LMICs, while concomitantly selecting for resistance genes whose persistence can last for months following treatment. Considerable heterogeneity in study methodology, timing and duration of sampling, and sequencing methodology in currently available research limit insights into antibiotic impacts on the microbiome and resistome in children in LMICs. More research is urgently needed to fill this gap in order to better understand whether antibiotic-driven reductions in microbiome diversity and selection of AMR genes place LMIC children at risk for adverse health outcomes, including infections with AMR-bearing pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Amsterdam UMC, location University of Amsterdam, Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands.
- Research Division, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
- Amsterdam Institute of Infection and Immunity, Infectious Diseases, Amsterdam University Medical Center, Amsterdam, the Netherlands.
- Department of Biostatistics, School of Public Health, University of Ghana, Accra, Ghana.
- Zambia National Public Health Institute, Ministry of Health, Lusaka, Zambia.
- Republic of Zambia State House, Lusaka, Zambia.
ORCID-Profile: Charlie C Luchen, Mwelwa Chibuye, Rene Spijker, Michelo Simuyandi, Caroline Chisenga, Samuel Bosomprah, Constance Schultsz, Daniel R Mende, Vanessa C Harris
Förderung
- Wellcome Trust
- The Netherlands Organization for Health Research and Development
- Health Holland TKI
Zitieren
APA
Luchen, C. C., Chibuye, M., Spijker, R., Simuyandi, M., Chisenga, C., Bosomprah, S., Chilengi, R., Schultsz, C., Mende, D. R., & Harris, V. C. (2023). Impact of antibiotics on gut microbiome composition and resistome in the first years of life in low- to middle-income countries: A systematic review. PLOS Medicine, 20(6), e1004235. https://doi.org/10.1371/journal.pmed.1004235
Vancouver
Luchen CC, Chibuye M, Spijker R, Simuyandi M, Chisenga C, Bosomprah S, et al. Impact of antibiotics on gut microbiome composition and resistome in the first years of life in low- to middle-income countries: A systematic review. PLOS Medicine. 2023;20(6):e1004235. doi:10.1371/journal.pmed.1004235
BibTeX
@article{Luchen2023,
author = {Luchen, Charlie C and Chibuye, Mwelwa and Spijker, Rene and Simuyandi, Michelo and Chisenga, Caroline and Bosomprah, Samuel and Chilengi, Roma and Schultsz, Constance and Mende, Daniel R and Harris, Vanessa C},
title = {Impact of antibiotics on gut microbiome composition and resistome in the first years of life in low- to middle-income countries: A systematic review},
journal = {PLOS Medicine},
year = {2023},
volume = {20},
number = {6},
pages = {e1004235},
doi = {10.1371/journal.pmed.1004235}
}
EUVIMED